The NADH Store, bringing Life's Energy to people, One Person at a Time
Cart 0
Copy of Alzheimers Disease

NADH to treat:

Copy of Alzheimers Disease

$ 16.22 $ 45.95

 Summary: 

Successful Alzheimer's TreatmentsGood news, after 6 months taking NADH daily, 100% of the Alzheimer’s Disease patients showed no evidence of cognitive deterioration and had significantly higher scores on the MDRS compared to the patients who didn’t take NADH. The NADH supplement is called ENADA / Co-E1. ENADA / Co-E1 is an NADH nutritional supplement that is a natural, energy-giving, co-enzyme found within every human cell. These are the results from a double blind, placebo controlled Alzheimer’s disease clinical study. NADH does not cure Alzheimer's.  After 6 months of treatment, the patients treated with 10mg of NADH daily showed no evidence of progressive cognitive deterioration (for the actual study results, see the link below) and had significantly higher total scores on the Mattis Dementia Rating Scale (MDRS) when compared to subjects taking a placebo (a sugar pill).   

In one of his latest seminars, Dr Birkmayer, (the Doctor that developed stabilized NADH in a oral tablet form,) stated that using a higher daily dose would have been better in the two FDA approved clinical trials. Dr Birkmayer recommended an Alzheimer’s disease patient should take 40mg (or more) of NADH daily to experience the positive improvements in their condition (The improvements were defined as the significantly higher total test scores on their MDRS tests.) (See the one hour long video Dr. Birkmayer Teaches about NADH: The Good and the Bad)

 

The Clinical Testing:

It was found that Alzheimer's disease and Parkinson's disease attack the brain tissue in similar ways (17). NADH has successfully been treating Parkinson's disease (see this website’s section called Parkinson’s disease). NADH is a co-enzyme which plays a key role in cellular energy production and stimulates dopamine production. In previous clinical trials, NADH has been shown to IMPROVE the cognitive functioning in patients with Parkinson’s disease, with patients suffering from depression, and patients with Alzheimer’s disease (when tested in open label trials).

To provide further validation of early Alzheimer’s disease testing results, a randomized, placebo-controlled, matched pairs, double-blind, 6-month clinical study was initiated. Twelve (12) pairs of subjects were matched for age and baseline scores on the Mattis Dementia Rating Scale (MDRS) and Mini Mental Stare Examination (MMSE). At the beginning of the clinical test, there were no baseline differences between the groups with respect to age, duration of the disease, months since diagnosis, or their performance on their testing. In a double blind study, neither the patient, nor the doctor administering the pills or testing the patients, know which pill is NADH, and which pill is the placebo (the sugar pill).

After 6 months of treatment, the patients treated with 10mg NADH daily, showed no evidence of progressive cognitive deterioration and had significantly higher scores on the MDRS compared to the patients treated with the placebo. Further analysis of the MDRS subscales reveal significantly better performance by NADH patients on measures of verbal fluency, visual constructional ability and a trend for better performance on a measure of abstract verbal reasoning. There were no differences between the groups on measures of attention, memory or the clinician ratings of dementia severity (Clinical Dementia Rating). The clinical study (the actual study results, see the link below) is technical in nature, difficult to read, and is usually read by healthcare professionals. We recommend taking the study to your healthcare professional and discuss its results.

Dr Birkmayer teaches, the younger patients, with a shorter duration of the disease, have a best chance to obtain the most significant improvements. This Alzheimer clinical trial proved after 6 months taking 10mg of NADH daily, 100% of the Alzheimer’s disease patients showed no evidence of cognitive deterioration and had significantly higher scores on the MDRS compared to the patients treated with the placebo. If the Alzheimer’s disease is in the most advanced stages, it is very difficult to show improvement. During the study, Dr, Birkmayer recommended 10mg of NADH daily. In a recent seminar, Dr. Birkmayer increased his recommended dosage to 60mg of NADH daily to treat chronic diseases. (See the one hour long video "Dr. Birkmayer Teaches about NADH: The Good and the Bad"). 

 

NADH: A Background

Glucose + Oxygen + NADH = ATP PowerThe NADH Alzheimer’s disease treatment comes from a coenzyme called NADH or nicotinamide adenine dinucleotide with the ‘H’ standing for hydrogen. What makes NADH promising is nature uses NADH to create mental and physical energy (called ATP) within all human cells. ATP energy creation takes place in a process called "cellular respiration." Cellular respiration is not breathing. Cellular respiration is like a cellular engine, creating energy used to power all living things (i.e., thought, memory, muscle movement, heart beats, etc.). Within the cellular respiration engine, all human cells bring glucose (fuel) and oxygen (air) together, and with the spark of NADH (spark plug) creates life's energy and power (ATP). ENADA / Co-E1 is an NADH nutritional supplement that has successfully reproduced the NADH co-enzyme in a stabilize form and is administered with a tablet. For more information about NADH in nature, take this website’s The Guided Tour.

Doctors that have tested NADH on patients have stated:

  • NADH is a safe, natural compound that has shown much promise with patients in Europe
  • Much more extensive research and testing is needed
  • A clinical trial for the treatment of Alzheimer’s disease patients is a significant step, down a long road to investigate the many potential benefits of this natural coenzyme called NADH.

NADH is a coenzyme. The American Heritage Dictionary defines a coenzyme as:

  • a non-protein organic substance that usually contains a vitamin or mineral and combines with a specific protein, to form an active enzyme system

NADH is not a drug, not a stimulant, and is non-toxic even in very large dosages (tested for 26 weeks at 1,000mg daily). Since NADH is already found within every human cell, NADH can safely be taken with any other medication. After extensive safety testing, it was proven NADH does not have any negative side effects and no adverse drug interactions. See this website’s section called Safety First for more information.

The most important things to remember about the NADH, which is found in every human cell, are:

  • NADH increases the levels of cellular energy (ATP). The more NADH cells have -- the more ATP-energy cells produce. It increases cell longevity.
  • NADH is a powerful antioxidant, a scavenger of free radicals. According to Dr. Passwater, "NADH may just be the most powerful antioxidant"
  • NADH is the active ingredient in cellular repair and DNA repair
  • NADH stimulates the immune system
  • NADH enhances the production of dopamine, a very important brain chemical (a neurotransmitter)
  • NADH increases the bio-availability of nitric oxide, known to provide increased blood flow, oxygen delivery, glucose uptake, muscle velocity, power output, and muscle growth

 

Alzheimer's disease: The illiness

Alzheimer's disease is a progressive disease that destroys memory and other important mental functions. Alzheimer's disease is the most common cause of dementia, which is a group of brain disorders resulting in the loss of intellectual and social skills. These changes interfere with day-to-day life.  

 

 

 

With Alzheimer's brain cells themselves degenerate (lose energy) and die.  Dying brain cells caused a steady decline in memory and mental functions.

Current Alzheimer's disease medications and management strategies may temporarily improve symptoms. This can sometimes help people with Alzheimer's disease maximize function and maintain independence.  
 
There is no cure for Alzheimer's disease. At first, increasing forgetfulness, mild confusion, and difficulty organizing thoughts may be the only symptoms.

 

Over time, the disease robs more of a person’s memory. The rate at which symptoms worsen varies from person to person. Brain changes associated with Alzheimer's disease leads to growing trouble:

  • Memory, repeating statements or questions over and over, not realizing the question has already been asked before
  • Forget conversations, appointments or events, and not remember them later
  • Memory, repeating statements or questions over and over, not realizing the question has already been asked before
  • Forget conversations, appointments or events, and not remember them later
  • Routinely misplace possessions, often putting them in illogical locations
  • Eventually forget the names of family members and everyday objects
  • Disorientation and misinterpreting spatial relationships
  • People with Alzheimer's disease lose their sense of what day it is, what season it is, where they are or even their current life circumstances
  • It disrupts the brain's ability to interpret what is seen, making it difficult to understand their surroundings. Eventually, these problems may lead to getting lost in familiar places.
  • Over time, the ability to read and write also declines.
  • Thinking and reasoning declines
  • Making judgments and good decisions declines
  • Responding effectively to everyday problems, such as food burning on the stove or unexpected driving situations, becomes increasingly challenging.
  • Planning and performing familiar tasks becomes a problem
  • Changes in personality and behavior and can affect the way a person acts and how they feel.

Alzheimer’s disease symptoms include:

  • Depression
  • Anxiety
  • Mood swings
  • Distrust in others
  • Irritability and aggressiveness
  • Changes in sleeping habits
  • Wandering
  • Loss of inhibitions
  • Delusions, such as believing something has been stolen
  • Many important skills are not lost until very late in the disease. These include the ability to read, dance and sing, enjoy old music, engage in crafts and hobbies, tell stories, and reminisce.

This is because information, skills and habits learned early in life are among the last abilities to be lost as the disease progresses. Capitalizing on these abilities can allow a person to continue to have successes and maintain a quality of life even when they are into the moderate phase of the disease.

     

     


    Alzheimer’s disease: Who Will Be Affected?

    Who will be affected by Alzheimer’s disease is unknown.  The following risks have been identified:
    • Age. Risk increases with age. Alzheimer’s is not a part of normal aging, but a person’s risk increases greatly after age 65. Nearly half of those older than age 85 have Alzheimer's.
    • Heredity. People with rare genetic changes are virtually guarantee they will develop Alzheimer's and begin experiencing symptoms as early as their 30s. The risk of developing Alzheimer's appears to be somewhat higher if a first-degree relative — your parent or sibling — has the disease.
    • Sex. Women may be more likely than are men to develop Alzheimer's disease, (in part because they live longer.)
    • Past head trauma. People who've had a severe head trauma or repeated head trauma appear to have a greater risk of Alzheimer's disease
    • Lifestyle and heart health: Evidence suggests that the same factors that put a person at risk for heart disease also increase the chances that they will develop Alzheimer's. Examples include:
        • Lack of exercise
        • Smoking
        • High blood pressure
        • High blood cholesterol
        • Elevated homocysteine levels
        • Poorly controlled diabetes
        • A diet lacking in fruits and vegetables
    • Lifelong learning and social engagement: Studies have found an association between lifelong involvement in mentally and socially stimulating activities and reduced risk of Alzheimer's disease.

     

     

    Alzheimer’s disease: Diagnosis & Current Treatment:

    Alzheimer's Disease PreventionIt should be known that Dr. G. Birkmayer, the creator of the stabilized form of NADH which was administered to the Alzheimer’s disease patients during this study is the son of Dr. W Birkmayer, the doctor that invented the L-dopa therapy (in 1961) that is used as a therapy to treat Parkinson’s patients. The Birkmayer family are the doctors that have successfully been treating 3,000+ Parkinson patients in Europe.

    Although Alzheimer’s disease can't be cured, there are medications that are known to improve Alzheimer’s disease symptoms. Current Alzheimer's medications can help (for a time) with memory symptoms and other cognitive changes. Two types of drugs are currently used to treat cognitive symptoms:

    Cholinesterase inhibitors. These drugs work by boosting levels of a cell-to-cell communication chemical depleted in the brain by Alzheimer's disease. Most people can expect to keep their current symptoms at bay for a time.

    Less than half of those taking these drugs can expect to have any improvement. Commonly prescribed cholinesterase inhibitors include donepezil (Aricept), galantamine (Razadyne) and rivastigmine (Exelon). The main side effects of these drugs include diarrhea, nausea and sleep disturbances.

    Memantine (Namenda). This drug works in another brain cell communication network and slows the progression of symptoms with moderate to severe Alzheimer's disease. It's sometimes used in combination with a cholinesterase inhibitor.

     

     

    Conclusion:

    Alzheimer's Hope for a CureNADH is found within all human cells, and there are no drug interactions, nor any adverse side effects when taking an NADH supplement. Dr. W. Birkmayer is the doctor attributed to creating the L-dopa therapy used to treat Parkinson’s disease. Since 1945, the Birkmayer family has been working on cognitive enhancement drugs and therapies. Dr. Birkmayer ran the clinical trial on the Alzheimer’s patients taking a daily NADH supplement. During the time of the study, Dr, Birkmayer recommended 10mg of NADH daily. In a recent seminar, Dr. Birkmayer increased his recommended dosage to up-to-60mg of NADH daily to treat chronic diseases. (See the one hour long video "Dr. Birkmayer Teaches About NADH: The Good and the Bad".) NADH increases the levels of cellular energy (ATP) and the longevity of the cell. NADH is a powerful antioxidant. It is the active ingredient in cellular repair and DNA repair. NADH stimulates the immune system, and most importantly NADH enhances the production of the brain chemical dopamine (and we know sufficient levels of dopamine are required for normal brain functions).

    The lack of physical or mental energy correlates with a lack of life’s energy called ATP. Every living cell produces ATP (also known as adenosine triphosphate) in a process called "cellular respiration." The human body uses ATP energy to enable the brain to provide: thinking, memory, mental clarity, etc. and enables muscles to provide: movement, stamina, physical endurance, etc. See this website’s section called ATP Energy for more information. Clinical studies have proven, the more NADH a cell has, the more ATP the cell will produce (see the link below). NADH is as important as oxygen and glucose (digested food) in the production of life’s energy (ATP). For more information about the production of NADH, take this website’s The Guided Tour.

    The brain and the muscles need to contain high levels of NADH. If the cellular NADH levels are depleted, the brain or muscles will no longer function properly, and brain cells die. How does NADH become depleted from the body? It is NOT known. Today, a scientific breakthrough has enabled NADH to be manufactured in a stabilized, tablet form. A person can restore NADH cellular levels by taking a nutritional supplement. High NADH levels, means higher levels of ATP (energy). The same NADH nutritional supplement used in the Alzheimer’s clinical study is available from this website or high quality nutritional supplement stores.

    A successful Alzheimer's disease treatment comes in an all natural supplement NADHWith this knowledge it stands to reason, taking an NADH daily supplement could help some Alzheimer’s disease sufferers. The clinical study states patients taking daily NADH showed no evidence of progressive cognitive deterioration and had significantly higher scores on the Mattis Dementia Rating Scale (MDRS) and Mini Mental Stare Examination (MMSE) when compared to the patients treated with the placebo (a sugar pill). NADH halts the deterioration of some brain functions, but depending on the Alzheimer’s disease phase, it may mean it does not help everyone and it does not help with all symptoms. But helping some of the sufferers, even a little is better than no help, or help with just treating the symptoms. The Alzheimer’s disease patients can take NADH with their medications.

    Take a copy of the clinical study to your healthcare professional and discuss the options.

     

     

    Read Publications / Clinical Studies:

    Alzheimer's Patients Taking NADH Showed No Evidence of Progressive Cognitive Deterioration

    NADH Demonstrates Cognitive Impairment Improvements in Alzheimer's Patients

    NADH Clinically Demonstrates Benefits For Alzheimer's Patients

    The More NADH in the Blood - the More ATP Energy is in the Cell

    ENADA CoE1 NADH Nutritional Supplementation Elevates ATP Energy Within the Cell


    Share this Product